Bio-Rad Laboratories (NYSE:BIO.B) Hits New 52-Week Low – What’s Next?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $223.15 and last traded at $223.15, with a volume of 26 shares traded. The stock had previously closed at $250.08.

Bio-Rad Laboratories Stock Down 10.8%

The business’s fifty day moving average price is $240.44 and its 200 day moving average price is $287.07. The company has a quick ratio of 4.85, a current ratio of 6.48 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $6.25 billion, a PE ratio of -3.43 and a beta of 0.82.

Bio-Rad Laboratories (NYSE:BIO.B) last released its earnings results on Thursday, May 1st. The company reported $2.54 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%. The business had revenue of $585.40 million for the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.